Müller CE (November 2009). „Prodrug approaches for enhancing the bioavailability of drugs with low solubility”. Chemistry & Biodiversity6 (11): 2071–83. DOI:10.1002/cbdv.200900114. PMID19937841.
Coller JK, Christrup LL, Somogyi AA (February 2009). „Role of active metabolites in the use of opioids”. European Journal of Clinical Pharmacology65 (2): 121–39. DOI:10.1007/s00228-008-0570-y. PMID18958460.
Müller CE (November 2009). „Prodrug approaches for enhancing the bioavailability of drugs with low solubility”. Chemistry & Biodiversity6 (11): 2071–83. DOI:10.1002/cbdv.200900114. PMID19937841.
Haffen E, Paintaud G, Berard M, Masuyer C, Bechtel Y, Bechtel PR (June 2000). „On the assessment of drug metabolism by assays of codeine and its main metabolites”. Therapeutic Drug Monitoring22 (3): 258–65. PMID10850391.
Raffa RB (July 1996). „A novel approach to the pharmacology of analgesics”. The American Journal of Medicine101 (1A): 40S–46S. PMID8764759.
Zhou SF, Zhou ZW, Yang LP, Cai JP (2009). „Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development”. Current Medicinal Chemistry16 (27): 3480–675. PMID19515014.
Coller JK, Christrup LL, Somogyi AA (February 2009). „Role of active metabolites in the use of opioids”. European Journal of Clinical Pharmacology65 (2): 121–39. DOI:10.1007/s00228-008-0570-y. PMID18958460.